These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

317 related items for PubMed ID: 15137068

  • 21. Effect of Bax deficiency on death receptor 5 and mitochondrial pathways during endoplasmic reticulum calcium pool depletion-induced apoptosis.
    He Q, Montalbano J, Corcoran C, Jin W, Huang Y, Sheikh MS.
    Oncogene; 2003 May 01; 22(17):2674-9. PubMed ID: 12730681
    [Abstract] [Full Text] [Related]

  • 22. Differential induction of apoptosis by tumor necrosis factor-related apoptosis-inducing ligand in human ovarian carcinoma cells.
    Lane D, Cartier A, L'Espérance S, Côté M, Rancourt C, Piché A.
    Gynecol Oncol; 2004 Jun 01; 93(3):594-604. PubMed ID: 15196850
    [Abstract] [Full Text] [Related]

  • 23. Adenovirus-mediated gene transfer of caspase-8 sensitizes human adenocarcinoma cells to tumor necrosis factor-related apoptosis-inducing ligand.
    Yasui H, Adachi M, Hamada H, Imai K.
    Int J Oncol; 2005 Feb 01; 26(2):537-44. PubMed ID: 15645141
    [Abstract] [Full Text] [Related]

  • 24. Sensitivity of prostate cells to TRAIL-induced apoptosis increases with tumor progression: DR5 and caspase 8 are key players.
    Hesry V, Piquet-Pellorce C, Travert M, Donaghy L, Jégou B, Patard JJ, Guillaudeux T.
    Prostate; 2006 Jun 15; 66(9):987-95. PubMed ID: 16541419
    [Abstract] [Full Text] [Related]

  • 25. IG20 (MADD splice variant-5), a proapoptotic protein, interacts with DR4/DR5 and enhances TRAIL-induced apoptosis by increasing recruitment of FADD and caspase-8 to the DISC.
    Ramaswamy M, Efimova EV, Martinez O, Mulherkar NU, Singh SP, Prabhakar BS.
    Oncogene; 2004 Aug 12; 23(36):6083-94. PubMed ID: 15208670
    [Abstract] [Full Text] [Related]

  • 26. Intracellular mechanisms mediating tocotrienol-induced apoptosis in neoplastic mammary epithelial cells.
    Sylvester PW, Shah S.
    Asia Pac J Clin Nutr; 2005 Aug 12; 14(4):366-73. PubMed ID: 16326643
    [Abstract] [Full Text] [Related]

  • 27. Nitric oxide sensitizes prostate carcinoma cell lines to TRAIL-mediated apoptosis via inactivation of NF-kappa B and inhibition of Bcl-xl expression.
    Huerta-Yepez S, Vega M, Jazirehi A, Garban H, Hongo F, Cheng G, Bonavida B.
    Oncogene; 2004 Jun 24; 23(29):4993-5003. PubMed ID: 15048072
    [Abstract] [Full Text] [Related]

  • 28. Bisphenol A diglycidyl ether-induced apoptosis involves Bax/Bid-dependent mitochondrial release of apoptosis-inducing factor (AIF), cytochrome c and Smac/DIABLO.
    Fehlberg S, Gregel CM, Göke A, Göke R.
    Br J Pharmacol; 2003 Jun 24; 139(3):495-500. PubMed ID: 12788809
    [Abstract] [Full Text] [Related]

  • 29. Type I and type II reactions in TRAIL-induced apoptosis -- results from dose-response studies.
    Rudner J, Jendrossek V, Lauber K, Daniel PT, Wesselborg S, Belka C.
    Oncogene; 2005 Jan 06; 24(1):130-40. PubMed ID: 15531922
    [Abstract] [Full Text] [Related]

  • 30. Regulation of apoptosis by p53 in UV-irradiated human epidermis, psoriatic plaques and senescent keratinocytes.
    Qin JZ, Chaturvedi V, Denning MF, Bacon P, Panella J, Choubey D, Nickoloff BJ.
    Oncogene; 2002 May 02; 21(19):2991-3002. PubMed ID: 12082529
    [Abstract] [Full Text] [Related]

  • 31. P-glycoprotein enhances TRAIL-triggered apoptosis in multidrug resistant cancer cells by interacting with the death receptor DR5.
    Park SJ, Wu CH, Choi MR, Najafi F, Emami A, Safa AR.
    Biochem Pharmacol; 2006 Jul 28; 72(3):293-307. PubMed ID: 16753135
    [Abstract] [Full Text] [Related]

  • 32. The proteasome inhibitor PS-341 overcomes TRAIL resistance in Bax and caspase 9-negative or Bcl-xL overexpressing cells.
    Johnson TR, Stone K, Nikrad M, Yeh T, Zong WX, Thompson CB, Nesterov A, Kraft AS.
    Oncogene; 2003 Aug 07; 22(32):4953-63. PubMed ID: 12902978
    [Abstract] [Full Text] [Related]

  • 33. Human soluble TRAIL/Apo2L induces apoptosis in a subpopulation of chemotherapy refractory nodal diffuse large B-cell lymphomas, determined by a highly sensitive in vitro apoptosis assay.
    Cillessen SA, Meijer CJ, Ossenkoppele GJ, Castricum KC, Westra AH, Niesten P, Muris JJ, Nijdam HF, van der Hem KG, Flens M, Hooijberg E, Oudejans JJ.
    Br J Haematol; 2006 Aug 07; 134(3):283-93. PubMed ID: 16848771
    [Abstract] [Full Text] [Related]

  • 34. Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo.
    Fulda S, Wick W, Weller M, Debatin KM.
    Nat Med; 2002 Aug 07; 8(8):808-15. PubMed ID: 12118245
    [Abstract] [Full Text] [Related]

  • 35. COX-2 inhibitors sensitize human hepatocellular carcinoma cells to TRAIL-induced apoptosis.
    Yamanaka Y, Shiraki K, Inoue T, Miyashita K, Fuke H, Yamaguchi Y, Yamamoto N, Ito K, Sugimoto K, Nakano T.
    Int J Mol Med; 2006 Jul 07; 18(1):41-7. PubMed ID: 16786154
    [Abstract] [Full Text] [Related]

  • 36. Synergistic induction of apoptosis in neuroblastoma cells using a combination of cytostatic drugs with interferon-gamma and TRAIL.
    Johnsen JI, Pettersen I, Ponthan F, Sveinbjørnsson B, Flaegstad T, Kogner P.
    Int J Oncol; 2004 Dec 07; 25(6):1849-57. PubMed ID: 15547726
    [Abstract] [Full Text] [Related]

  • 37. ARK5 suppresses the cell death induced by nutrient starvation and death receptors via inhibition of caspase 8 activation, but not by chemotherapeutic agents or UV irradiation.
    Suzuki A, Kusakai G, Kishimoto A, Lu J, Ogura T, Esumi H.
    Oncogene; 2003 Sep 18; 22(40):6177-82. PubMed ID: 13679856
    [Abstract] [Full Text] [Related]

  • 38. Synergistic inhibition of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human pancreatic beta cells by Bcl-2 and X-linked inhibitor of apoptosis.
    Ou D, Wang X, Metzger DL, James RF, Pozzilli P, Plesner A, Korneluk RG, Verchere CB, Tingle AJ.
    Hum Immunol; 2005 Mar 18; 66(3):274-84. PubMed ID: 15784465
    [Abstract] [Full Text] [Related]

  • 39. Role of intracellular glutathione in cell sensitivity to the apoptosis induced by tumor necrosis factor {alpha}-related apoptosis-inducing ligand/anticancer drug combinations.
    Meurette O, Lefeuvre-Orfila L, Rebillard A, Lagadic-Gossmann D, Dimanche-Boitrel MT.
    Clin Cancer Res; 2005 Apr 15; 11(8):3075-83. PubMed ID: 15837763
    [Abstract] [Full Text] [Related]

  • 40. Oncogenic Ras sensitizes normal human cells to tumor necrosis factor-alpha-related apoptosis-inducing ligand-induced apoptosis.
    Nesterov A, Nikrad M, Johnson T, Kraft AS.
    Cancer Res; 2004 Jun 01; 64(11):3922-7. PubMed ID: 15173003
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.